The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Alvogen sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.

Smarter leaders trust GlobalData


Data Insights Alvogen Inc, United States Revenue

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

Alvogen is a pharmaceutical company that develops, manufactures and markets generic pharmaceuticals, brand and over the counter (OTC) products. The company offers generic medications in the therapeutic areas of oncology, cardiology, respiratory, neurology and gastroenterology. It also provides services such as product development, contract manufacturing and research services. Alvogen’s OTC categories include food supplements, OTC medicines, cosmetics and medical devices. It offers products in various dosage forms of solid oral dosage, modified release tablets, soft gelatin capsules, creams, ointments, transdermals and injectables. The company operates through its manufacturing and development facilities located in the US, Taiwan, South Korea and Romania. Alvogen is headquartered in Pine Brook, New Jersey, the US Key subsidiaries of Alvogen include Alvogen Emerging Markets, Alvogen Malta Operations (ROW), Alvogen Malta Group Services, Omega Bittner and County Line Pharmaceuticals.

The key metrics of Alvogen related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:

As Alvogen is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Alvogen.

For a detailed understanding of the performance of Alvogen, buy the report here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

GlobalData’s revenue report leverages GlobalData’s SKU tracker, which contains real-world, purchasing data from the US healthcare institutions.